Progress in cancer chemotherapy with special stress on molecular-targeted therapy

Japanese Journal of Clinical Oncology
Nagahiro Saijo

Abstract

Numerous molecular-targeted drugs have been developed based on the progress in the study of molecular biology. Among them, some of the antibodies and small molecule tyrosine kinase inhibitors have been approved for clinical use. Standard therapies against common cancers have completely been changed. Individualized treatments have been possible in pharmacogenomically specific populations. Unbelievably improved progression-free and/or overall survivals have been achieved and cure rate has also improved in surgically resected patients by using molecular-targeted therapy. Prognostic and/or predictive factors have been identified and biomarker testing has become mandatory for human epidermal growth factor receptor 2 expression/amplification in breast cancer and gastric cancer, Kras mutation in colon cancer and epidermal growth factor receptor mutation in lung cancer. The development of active molecular-targeted therapy and more validated markers could enable the increment of curative populations even in advanced malignancies.

References

Mar 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J BaselgaL Norton
Mar 10, 2001·Clinical Pharmacology and Therapeutics·UNKNOWN Biomarkers Definitions Working Group.
Jun 4, 2004·The New England Journal of Medicine·Herbert HurwitzFairooz Kabbinavar
Feb 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kathy D MillerHope S Rugo
Mar 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tetsuya MitsudomiYasushi Yatabe
Jun 16, 2005·Journal of the National Cancer Institute·Richard Simon
Jul 7, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Toshimi TakanoTomohide Tamura
Sep 8, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard Simon
Jan 13, 2006·Nature Clinical Practice. Oncology·Rakesh K JainJay S Loeffler
Mar 23, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark J Ratain
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric J SmallRobert M Hershberg
Sep 8, 2006·The New England Journal of Medicine·Ken A OlaussenUNKNOWN IALT Bio Investigators
Dec 15, 2006·The New England Journal of Medicine·Alan SandlerDavid H Johnson
Feb 23, 2007·The New England Journal of Medicine·Zhong ZhengGerold Bepler
Apr 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce J GiantonioUNKNOWN Eastern Cooperative Oncology Group Study E3200
Jul 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·George SimonGerold Bepler
Dec 28, 2007·The New England Journal of Medicine·Kathy MillerNancy E Davidson
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lainie P MartinRussell J Schilder
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard B SaltzJim Cassidy
May 27, 2008·Cancer Treatment Reviews·Nagahiro Saijo
Dec 10, 2008·Proceedings of the National Academy of Sciences of the United States of America·Manabu SodaHiroyuki Mano
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Feb 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin ReckChristian Manegold
Apr 25, 2009·Nature Reviews. Clinical Oncology·Nagahiro SaijoHideo Kunitoh
Jun 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David J Gallagher, Nancy E Kemeny
Jun 18, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Satoshi MoritaToshihiro Nukiwa
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka

❮ Previous
Next ❯

Citations

Dec 6, 2012·Journal of Pain and Symptom Management·David HuiEduardo Bruera
Jul 23, 2018·European Journal of Pharmacology·Yeuan Ting LeeChern Ein Oon
Nov 24, 2021·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·X XieB Bao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Craig C EarleJohn Z Ayanian
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Craig C EarleSusan D Block
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Siew Tzuh TangTsang-Wu Liu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Elizabeth A GrunfeldAmanda J Ramirez
© 2021 Meta ULC. All rights reserved